Constellation Pharmaceuticals (CNST) a 'High-Conviction Idea' with ASH Confirmed - RBC
Tweet Send to a Friend
RBC Capital analyst Brian Abrahams reiterated an Outperform rating and $20.00 price target on Constellation Pharmaceuticals (NASDAQ: CNST), saying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
